Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

Impact of Sofosbuvir and Daclatasvir therapy on the expression levels of inflammasomes in chronic hepatitis C infected patients

Hepatitis C Patients with Progress of Disease Severity: Biochemical and Immunological studies

Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection

Study the Effect of Sofosbuvir, Daclatasvir and Ribavirin on Hematologic Profile, ‎Vitamin B12 and Folic Acid Levels in HCV-Related Cirrhotic Patients‎

Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Impact of Sustained Virological Response on ‎Metabolic Changes and Vitamin-D Status in ‎Patients with Hepatitis C Viral Infection Treated by ‎Direct Acting Antiviral drugs

Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients

Impact of sustained virologic response on glycemic control among diabetic patients with hepatitis C virus-related liver disease